BMRA Margin dodolan resik Biomerica, Inc.

Logo grafis Biomerica, Inc (BMRA)

The development of IBS-class rapid tests and gastrointestinal in-vitro diagnostics is driving efficiency growth for Biomerica, Inc. (BMRA). The net sales margin spread on GURU.Markets reflects this trend, where the -115.50 mark indicates the profitability level. Stable demand for testing reduces the impact of economic cycles, while the expansion of the pharmacy network and insurance recognition of methodologies determine the future financial results of Biomerica, Inc. (BMRA).

Tingkat bathi resik Biomerica Inc (BMRA): kanggo periode 04.07.2022 - 20.11.2026

Rincian analitis lan laporan data perusahaan Biomerica, Inc (BMRA)

- nilai pasar lan prakiraan target analis:
Analisis wiwitan perusahaan:Biomerica, BMRA
Barang unggulan Biomerica Inc.

Sales margin measures the share of net profit in every dollar of revenue, demonstrating the efficiency of cost management. An investor assesses business resilience to shocks by analyzing the sales margin trajectory to identify hidden cost growth. This ratio separates real profitability from nominal turnover growth. For Biomerica, Inc. (BMRA), this is a critical profitability indicator when distributing home tests through pharmacies. The metric confirms the financial viability of the strategy to implement non-invasive cancer diagnostics.

Karo sapa Biomerica, Inc. saingan

A (Agilent Technologies) - Rentabilitas dodolan miturut bathi resik|DGX: Rentabilitas resik perusahaan|Margin resik Illumina Platform|EXAS (Exact Sciences) - Rentabilitas resik perusahaan|Rentabilitas dodolan miturut bathi resik RVTY (PerkinElmer)|Bio-Rad - Rentabilitas dodolan resik|Margin dodolan resik NNNN (Anbio)|Tingkat bathi resik SHC|QDEL - Margin resik|OPK: Margin resik|caredx.com (CDNA) - Margin resik|MRVI (Maravai LifeSciences) - Margin resik|FLGT (Fulgent) - Margin dodolan resik|Standard BioTools Inc (LAB) - Margin dodolan perusahaan|Margin dodolan resik CTKB|Rentabilitas dodolan miturut bathi resik OraSure Technologies Inc OSUR|Margin dodolan resik XGN (Exagen Diagnostics)|Margin dodolan resik mdxhealth.com MDXH|LUCD - Margin resik|PRE: Margin resik|IMDX (Insight Molecular Diagnostics Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan miturut bathi resik Trinity Biotech PLC|PRPH (prophaselabs.com) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik Ainos, Inc. (AIMD)|Margin dodolan resik CODX|HSCS (HeartSciences) - Tingkat bathi resik|Margin dodolan resik CDIO (Cardio Diagnostics)|ONCO - Rentabilitas dodolan miturut bathi resik|VRAX: Rentabilitas dodolan miturut bathi resik|bluejaydx.com (BJDX) - Rentabilitas dodolan miturut bathi resik|AWH: Margin dodolan resik|AXDX: Rentabilitas resik perusahaan|CNTG (CENTOGENE N.V.) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik Enzo Biochem, Inc. (ENZ)|FRES - Margin bathi resik|Genetic Technologies Limited (GENE) - Tingkat bathi miturut bathi resik|Margin dodolan resik ME (23andme.com)|Psychemedics Corp. (PMD) - Margin resik